General Anesthesia
Post on 04-Dec-2015
221 Views
Preview:
DESCRIPTION
Transcript
1
General Anesthetics
P h a r m a c o l o g y 6 0 4
K a t h e r i n e L . N i c h o l s o n , D . V . M . , P h. D .
D e p t . P h a r m a c o l o g y / T o x i c o l o g y
k l n i c h o l @h s c . vcu . edu
History of Anesthes ia
General Anesthesia -
Characterist ics• D e f i n i t i o n ( G & G ) - “ R e v e r s i b l e d e p r e s s i o n o f C N S
func t i on r e su l t i ng i n l o s s o f r e sponse t o and pe r cep t i on o f
a l l ex te rna l s t imul i . ”
- P r o d u c e r e v e r s i b l e " s l e e p "
- P r o d u c e a n a l g e s i a
- S u p p r e s s r e f l e x e s
- P r o d u c e m u s c l e r e l a x a t i o n
- P r o d u c e A m n e s i a
- D o n o t s u p p r e s s r e s p i r a t o r y a n d c a r d i o v a s c u l a r
f u n c t i o n
- I n e x p e n s i v e a n d e a s y t o a d m i n i s t e r
Balanced Anesthesia
• I d e a l g e n e r a l a n e s t h e t i c d o e s n o t e x i s t .
• C o m b i n a t i o n s o f d r u g s t o a c c o m p l i s h w h a t o n e
a n e s t h e t i c c a n n o t d o a l o n e .
• A g e n t s u s e d f o r b a l a n c e d a n e s t h e s i a a r e -
– H y p n o t i c s
– N e u r o m u s c u l a r b l o c k i n g a g e n t s
– A n a l g e s i c s
C O M B I N A T I O N O F D R U G S C A N L O W E R D O S E S O F
E A C H D R U G T O P R O D U C E T H E S A M E O R G R E A T E R
E F F E C T O N P A T I E N T
Four Stages of Anesthesia
• Stage I - ana lges ia
• Stage II - del i r ium
• Stage III - surgical anesthesia
• Stage IV - respiratory paralysis
Types of General Anesthetics
Extremely diverse group of chemicals which
produce a similar endpoint
• Inhalant or volati le
• Injectable ( intravenous)
2
Inhalational Anesthetics
• Administered as vapors or gases
• Special set of physical principles govern
absorption, distr ibution and elimination
• Partial pressure - proportional to the
concentration of anesthetic in gas or tissue
at equilibrium
MAC: Minimum Alveolar
Concentration• Potency measure
• 1 MAC is the concentrat ion necessary to
prevent responding in 50% of populat ion
1.0
0.8
0.6
0.4
0.2
0.0
0.40.30.20.10.0
[Halothane] mM
1.51.00.50.0
[Halothane] % atm
MAC
Fraction of Anesthetized
Patients
Factors affecting MAC
F a c t o r s d e c r e a s i n g M A C :
• Hypotension
• Anemia ( PCV < 13%).
• Hypothermia
• Metabolic acidosis
• Extreme hypoxia (PaO2 < 38 mmHg )
• Age: old animal require less anesthetic
• Premedication (opioids, sedatives, tranquilizers)
• Local anesthetics
• Pregnancy
• Hypothyroidism
• Concurrent use of nitrous oxide
F a c t o r s i n c r e a s i n g M A C :
• Increasing body temperature
• Hyperthyroidism
• Hypernatremia
F a c t o r s N O T a f f e c t i n g M A C
• Type of stimulation
• Duration of anesthesia• Species
• Sex• PaCO2 between range of 14-95 mmHg• Metabolic alkalosis
• PaO2 between range of 38-500 mmHg• Hypertension• Potassium
Solubility & Pharmacokinetics
• S o l u b i l i t y e x p r e s s e d a s p a r t i t i o n c o e f f i c i e n t s
( a r a t io o f the concen t ra t ion o f the agen t in two phases a t
e q u i l i b r i u m )
• B l o o d : g a s p a r t i t i o n c o e f f i c i e n t
– S o l u b i l i t y i n b l o o d
– ma in f ac to r t ha t de t e rmines t he r a t e o f i nduc t i on and
r e c o v e r y
• O i l : g a s p a r t i t i o n c o e f f i c i e n t
– fa t so lub i l i ty
– d e t e r m i n e s t h e p o t e n c y o f a n a n e s t h e t i c ( a s w e l l a s k i n e t i c s )
Induction and Recovery
• T h e l o w e r t h e b l o o d : g a s p a r t i t i o n c o e f f i c i e n t t h e f a s t e r t h e
i n d u c t i o n a n d r e c o v e r y
– T h e l o w e r t h e s o l u b i l i t y i n b l o o d , t h e f a s t e r t h e p r o c e s s o f e q u i l i b r a t i o n
– L e s s d r u g h a s t o b e t r a n s f e r r e d v i a t h e l u n g s t o t h e b l o o d i n o rde r t o ach ieve a g iven pa r t i a l p re s su re
– A s i n g l e l u n g f u l o f a i r c o n t a i n i n g a l o w-so lub i l i ty agen t wi l l b r i n g t h e p a r t i a l p r e s s u r e i n t h e b l o o d c l o s e r t o t h a t o f t h e insp i red a i r
• R e c o v e r y i s t h e s a m e
L o w s o l u b i l i t y i n b l o o d = f a s t i n d u c t i o n a n d r e c o v e r y
H i g h s o l u b i l i t y i n b l o o d = s l o w e r i n d u c t i o n a n d r e c o v e r y
MAC Partition Coefficients
Anesthetic (% atm) (mM) Water:Gas Oil:Gas Oil:Water
Methoxyflurane 0.16 0.26 4.2 850 200
Halothane 0.77 0.19 0.63 200 320
Isoflurane 1.2 0.24 0.54 91 170
Enflurane 1.7 0.52 0.78 97 120
Diethylether 1.9 8.22 11 57 5.2
Sevoflurane 2.0 0.29 0.37 47 130
Fluroxene 3.4 0.95 0.71 67 94
Desflurane 6.0 0.52 0.22 19 86
Cyclopropane 9.2 0.72 0.20 9.7 49
Butane 20 0.15 0.019 15 790
Ethylene 67 2.2 0.085 1.1 13
Xenon 71 2.1 0.075 1.8 24
Nitrous Oxide 101 15 0.39 1.3 3.3
Anesthetic Properties
P o t e n c y BloodSolubility
BrainSolubility
3
Nitrous Oxide
• Relatively safe
– M i n i m a l e f f e c t s o n h e a r t r a t e a n d b l o o d
p r e s s u r e
– L i t t l e e f f e c t o n r e s p i r a t i o n
• Low blood solubil i ty (quick recovery)
• MAC value is 105% - Needs other agents
for surgical anesthesia
• Weak anesthet ic , powerful analgesic
Nitrous Oxide - Disadvantages
• Cannot produce anesthesia without hypoxia
• Poor muscle relaxation
• Diffuses into closed spaces
• Inhibits vitamin B-12 metabol i sm
• Inhibits methionine synthetase (precursor to
DNA synthes is )
• Abuse l iabi l i ty
Anesthetics - Halogenated ethers8 1 2
C C O C
6 5 4
37
MW 1 2 3 4 5 6 7 8
Diethyl ether 74 H H CH H H H H H
Fluroxene 126 H H =CH H F F F
Methoxyflurane 165 F H H H F Cl H Cl
Desflurane 168 H F H F F F F F
Isoflurane 184 H F H F Cl F F F
Enflurane 184 F F H F F Cl H F
Sevoflurane 200 H H F H CF F F F3
3
2
Halothane (Fluothane®)
• Most potent inhalat ional anesthet ic
– M A C o f 0 . 7 5 %
• Very soluble in blood and adipose tissue
– P r o l o n g e d e m e r g e n c e
• Inhibits sympathetic response to painful
s t imul i
Halothane - Disadvantages
• Decreases respiratory drive
• Depresses cardiovascular function
• Sensi t izes myocardium -can lead to
ventricular arrhythmias
• “ Halo thane Hepatitis”
• Malignant Hyper thermia
Enflurane ( Ethrane®)
• S t a b l e , n o n f l a m m a b l e l i q u i d w i t h p u n g e n t o d o r
• M A C 1 . 6 8 %
• C a r d i a c e f f e c t s
– d e p r e s s i o n a n d d e c r e a s e d s y s t e m i c v a s c u l a r r e s i s t a n c e
– i n h i b i t s s y m p a t h e t i c b a r o r e f l e x r e s p o n s e
– s e n s i t i z e s m y o c a r d i u m
• D e c r e a s e s r e s p i r a t o r y d r i v e
• M e t a b o l i s m o n e - t e n t h t h a t o f h a l o t h a n e
– r e l e a s e s f l u o r i d e i o n -- r e n a l t o x i c i t y
• E p i l e p t i f o r m E E G p a t t e r n s
4
Isoflurane (Forane®)• Less soluble than ha lo thane
• M A C o f 1 . 3 0 %
• E x c e l l e n t m u s c l e r e l a x a n t
• D e p r e s s e s r e s p i r a t o r y d r i v e a n d v e n t i l a t o r y
r e s p o n s e s- - (less than enthrane)
• D e p r e s s e s c a r d i o v a s c u l a r s y s t e m
– M y o c a r d i a l d e p r e s s a n t (less than enthrane)
– I n h i b i t s s y m p a t h e t i c baroref lex r e s p o n s e (less than enthrane)
– P r o d u c e s m o s t s i g n i f i c a n t r e d u c t i o n i n s y s t e m i c
v a s c u l a r r e s i s t a n c e
• S e n s i t i z e s m y o c a r d i u m - less than enthrane
Isof lurane Toxic Side Effects
• Lit t le metabolism (0.2%) -- low potential of
organotoxic metaboli tes
• No EEG act ivi ty l ike enflurane
• Bronchoir r i ta t ing , la ryngospasm
Sevoflurane (Ultane®, Sevorane®)and Desflurane(Suprane®)
• Low solubil i ty in blood-- produces rapid
induct ion and emergence
• Minimal systemic effects-- mild respiratory
and cardiac suppression
• Few side effects
• Expensive0.001
0.01
0.1
1
10
100
Mou
se M
AC (at
m)
0.01 0.1 1 10 100 1000
Olive Oil : Gas Partition Coefficient
HAL
ISO ENF
FLU
MOF
DEE
CHL
DDM
PFECTF
SHF
CYC
ETHNO2 XEN HYD
NIT
KRY
ARG
Potency k
Meyer Overton Correlation
H A L H a l o t h a n e
I S O I s o f l u r a n e
E N F E n f l u r a n eS E V S e v o f l u r a n e
F L U F l u r o x e n eD E S D e s f l u r a n e
C Y C C y c l o p r o p a n eM O F M e t h o x y f l u r a n e
D E E D i e t h y l e t h e rC H L C h l o r o f o r m
D D M D i c h l o r o d i f l u r o r m e t h a n e
P F E P e r f l u o r o e t h a n eC T F C a r b o n t e t r a f l u r o i d e
S H F S u l f u r h e x a f l u o r i d eC Y C C y c l o p r o p a n e
E T H E t h y l e n eN O 2 N i t r o u s o x i d e
X E N X e n o nNIT N i t r o g e n
K R Y K r y p t o nA R G A r g o n
Lipid- Based Theories of
Anesthetic Action
Hypothesized anesthetic effect was due to
disruption of l ipid bi layer of plasma
membranes .
… . h o w e v e r … . .
• V o l u m e e x p a n s i o n b y n o n a n e s t h e t i c c o m p o u n d s
• C o r r e l a t i o n b e t w e e n f l u i d i t y a n d a n e s t h e t i c l e v e l s o n l y
o c c u r r e d a t h i g h c o n c e n t r a t i o n s .
• S m a l l c h a n g e s i n t e m p e r a t u r e d i d p r o d u c e s i g n i f i c a n t
f l u i d i t y c h a n g e s w i t h o u t c a u s i n g a n e s t h e s i a w h i l e l a r g e
c h a n g e s i n a n e s t h e t i c c o n c e n t r a t i o n p r o d u c e d s m a l l
c h a n g e s i n f l u i d i t y .
• C u t - o f f e f f e c t - M- O r u l e o n l y h o l d s u p t o a c e r t a i n s i z e
• I n h a l a n t a n e s t h e t i c s s h o w s t e r e o s e l e c t i v i t y i n e f f e c t s
5
Protein-based theories of
Anesthetic Action
Anesthetics bind to hydrophobic/ lipophilic
sites on proteins.
– i n d u c e / p r e v e n t c o n f o r m a t i o n a l c h a n g e
– a l t e r k i n e t i c s o f c o n f o r m a t i o n a l c h a n g e s
– c o m p e t e w i t h l i g a n d s
Ok, so which receptors
mat ter….
• G A B AA
• Glu tamate (AMPA and NMDA)
• Glycine ( s t rychnine-sensitive, in spinal cord
and brainstem)
• Nicotinic A C h
Injectable anesthetics
• A d v a n t a g e s
– m i n i m a l e q u i p m e n t
– ‘ d i r e c t ’ C N S a c c e s s
– w i d e v a r i e t y o f a g e n t s , t e c h n i q u e s
• D i s a d v a n t a g e s
– r e c o v e r y d e p e n d e n t o n u n c o n t r o l l a b l e
factors
– i n d i v i d u a l v a r i a t i o n i n d r u g r e s p o n s e
– p o t e n t i a l f o r d r u g ‘ a c c u m u l a t i o n ’
Barbiturates
• Phenobarbital
• Pentobarbi tal Sodium
• Thiopental Sodium
• Thiamylal Sodium
• Methohexital
Barbiturates - General
• Very alkaline - very irritating to tissues
• Depress polysynapt ic responses in the CNS
• Effect on GABA receptors
– D e p r e s s R e t i c u l a r A c t i v a t i n g S y s t e m
– D e p r e s s s y m p a t h e t i c n e r v o u s s y s t e m
• Poor analgesics
• Excitement at low doses
• Low therapeutic index!
Cardiopulmonary Effects
• Arrhy thmogenic!!!
– T r a n s i e n t V P C s & v e n t r i c u l a r b i g e m i n y
• Transient , moderate decrease in blood
pressure
• Decrease cardiac contracti l i ty
• Vascular effects variable, but in general
cause mild vasodilatat ion
• Respiratory depressants
6
Propofol
• G A B AA posit ive modulator
• Solubi l ized in an emulsion
• Rapid onset, short duration of
action, rapid smooth recoveries w/o ‘hangover’
• Useful for induction &/or maintenance (by
constant infusion)
• Mild to moderate hypotens ion , may produce
bradyarrhythmias
• Respiratory depressant , may produce apnea
Disadvantages
• Expensive
• Moderate hypotension, possible
bradyarrhythmias , respiratory depression
(apnea not uncommon)
• Poor analgesia (need high doses)
• Drug vehicle supports bacterial growth
Etomidate
• G A B AA posit ive modulator
• non-barbi turate ul t rashort sedat ive/hypnotic
• minimal cardiovascular effects
• rapid onset/recovery
• wide safety margin
Dissociative Anesthetics
• Ketamine
• Tiletamine
• NMDA receptor channel blockers
• Produces amnesia, superficial analgesia, and
catalepsy
• Dissociates the cortex from lower centers
• Both excitatory & depressant effects on EEG
• Actually has posit ive effects on CV measures
and minimal respiratory depression
Problems.. .
• Seizures
• Muscle r igidity
• Poor visceral analges ia
• Increased secretions
• Poor recoveries - delirium
• Increased myocardial work load
Neuroleptanalgesia
• combinat ion of opioid + tranquil izer/sedative
• produces state of l ight ‘anesthesia’
• useful for debilitated or geriatric patients
• eg fentanyl/diazepam; droper idol / fentanyl;
oxymorphone /midazolam; etc. . .
7
Overview of mechanisms
of action for general
anesthetic…..
Ion Channels and Anesthesia
• G A B A A - p r i m a r y a n e s t h e t i c t a r g e t
– A c t a s m o d u l a t o r s , n o t d i r e c t a g o n i s t s
– I n c r e a s e c u r r e n t i n d u c e d b y l o w l e v e l
G A B A b y > 5 0 %
– W o r k b y p r o l o n g i n g c h a n n e l o p e n -
t i m e
– Inha l an t s , ba rbs , b e n z o ’ s , s te ro ids ,
p ropo fo l
• G l y c i n e - i m p o r t a n t f o r s p i n a l c o r d a n d
l o w e r b r a i n s t e m
G A B A A R c a c t i v a t i o n
Ion Channels and Anesthesia
• G l u t a m a t e - N M D A , A M P A & K a i n a t e
– D i s s o c i a t i v e anes the t i c s
– R e l a t i v e l y i n s e n s i t i v e t o i n h a l a n t s ( ? ) a n d
b a r b i t u r a t e s
• n A C h - m o s t s i m p l e a n e s t h e t i c s c a n s t a b i l i z e
d e s e n s i t i z e d f o r m
– D e f i n i t e l y i n v o l v e d i n m a n y i n h a l a n t e f f e c t s
– Inc reas ing in t e re s t fo r ro l e wi th o the r anes the t i c s
• V o l t a g e g a t e d i o n c h a n n e l s -
– N a + , K+ , Ca ++
– D o n o t a p p e a r t o p l a y a r o l e i n a n e s t h e s i a
Potential Receptor Targets
Anesthetic GABAA Glycine Neuronal
nACHAMP A NMDA
Halothane +++ +++ - - - - - - -/0
N2 O +++ +/0 ? -/0 - - -
Xenon 0 ? ? 0 - - -
Barbiturates +++ +/0 - - - - - - 0
Ketamine 0 0 - - - 0 - - -
Propofol +++ +++ -/0 -/0 -/0
Neuroste roids +++ 0 -/0 0 0
top related